Childhood cancers trials in Türkiye

In Türkiye 14 Also abroad 2459

14 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Ankara, Bornova, Istanbul, Yüreğir
Age
12 years and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
Phase 3Taking people
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Where
Adana, Ankara, Cordaleo, Istanbul
Age
15 years and over
People
800 worldwide
Run by
AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00
Phase 4Taking people
Asciminib Roll-over Study
Where
Samsun
Age
7 years to 100 years
People
347 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00
Phase 2/3Taking people
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Where
Ankara
People
1,541 worldwide
Run by
Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00
Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Ankara, Bornova
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
Phase 3Taking people
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Where
Istanbul
Age
1 year to 64 years
People
750 worldwide
Run by
Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00
No phaseTaking people
CHARM Hepatocellular Carcinoma MEA Study
Where
Ankara, Erzurum, Istanbul, Izmir
People
4,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07650773
Phase 1/2Taking people
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Where
Ankara, Izmir
Age
1 month to 17 years
People
50 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00
Phase 2Taking people
Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
Where
Ankara, Istanbul, Kayseri
Age
0 months to 18 years
People
95 worldwide
Run by
Helsinn Healthcare SA
See details and how to joinNCT06904235
No phaseTaking people
A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region
Where
Ankara, Antalya, Istanbul, Izmir
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07065344
Phase 2/3Taking people
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Where
Ankara, Antalya, Istanbul, Izmir, Kayseri
Age
1 month to 18 years
People
1,800 worldwide
Run by
St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00
No phaseTaking people
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
Where
Ankara, Istanbul
People
200 worldwide
Run by
Immune Oncology Research Institute
See details and how to joinNCT05430971
No phaseEnrolling by invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
Where
Yenimahalle
Age
1 day and over
People
500 worldwide
Run by
Prof. Valérie Mc Lin
See details and how to joinNCT06041906
No phaseTaking people
International Chronic Myeloid Leukemia Pediatric Study
Where
Görükle
Age
Up to 18 years
People
750 worldwide
Run by
Poitiers University Hospital
See details and how to joinNCT01281735